Abemaciclib increases the risk of venous thromboembolism in breast cancer: Integrate meta-analysis, pharmacovigilance database analysis, and in vitro validation
- 7 September 2024
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 130, 102827
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Peking University First Hospital
This publication has 46 references indexed in Scilit:
- Efficacy of CDK4/6 inhibitors combined with endocrine therapy in HR+/HER2− breast cancer: an umbrella reviewJournal of Cancer Research and Clinical Oncology, 2024
- Patient characteristics, treatment patterns, and outcomes of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer patients prescribed cyclin-dependent kinase 4 and 6 inhibitors: large-scale data analysis using a Japanese claims databaseBreast Cancer Research and Treatment, 2022
- nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HER2– metastatic breast cancerBreast Cancer Research and Treatment, 2022
- Venous and arterial thrombosis associated with abemaciclib therapy for metastatic breast cancerCancer, 2022
- Risk factors associated with venous thromboembolism in breast cancer: a narrative reviewSupportive Care in Cancer, 2022
- Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2–advanced breast cancer: GEICAM/2014–12 (FLIPPER)European Journal of Cancer, 2022
- Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survivalAnnals of Oncology, 2021
- Real-World Experience of Palbociclib-Induced Adverse Events and Compliance With Complete Blood Count Monitoring in Women With Hormone Receptor–Positive/HER2-Negative Metastatic Breast CancerClinical Breast Cancer, 2019
- Breast Cancer TreatmentJAMA, 2019
- Incidence of venous thromboembolism in patients with cancer – A cohort study using linked United Kingdom databasesEuropean Journal of Cancer, 2013